ORF Genetics has completed an EUR 5 million equity financing round, with participation from both new and existing shareholders.
ORF produces specialized proteins in barley plants, which are a key component in the production of cultivated meat. Cultivated meat production has advanced rapidly over the past decade, and ORF has developed its MESOKINE line of growth factors, tailored to the needs of the cultivated meat producers. ORF‘s growth factors are trusted by leading players in the cultivated meat market.
The financing enables the company to support the scale-up of growth factor production for cultivated meat producers. ORF plans to extend the round to up to EUR 7 million, with final closing expected in mid-October.
Arctica Finance is acting as advisor to ORF Genetics in the transaction.
